Mineral ·Emerging evidence ·Reviewed May 2026
Ultra-trace mineral that mimics insulin action for blood sugar support.
The bottom line
Evidence rating emerging. Most-documented uses: blood sugar support, insulin sensitivity. 16 sources indexed (1996–2025), with 11 interaction records on file.
Core mechanism
Vanadyl ion inhibits protein tyrosine phosphatase 1B (PTP1B), enhancing insulin receptor signaling. Stimulates glucose transporter (GLUT4) translocation to cell surface.3,4
Dosing protocol
Avoid vanadyl sulfate doses above 1.8 mg/day due to GI toxicity. Trace mineral with limited evidence for routine use.13
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes Vanadyl Sulfate.
Weak estimate: assumes 10-50 mcg/day. Vendor basis: iHerb, Vitacost, Amazon marketplace, and specialty trace-mineral products; standalone retail options are sparse. Updated 2026-05-28.
How much you'd eat to match a supplemental dose.
Vanadium content varies widely and routine supplementation is not usually diet-equivalent.
Dose: 10-50 mcg daily4
Timing: With meals
Clinical dose evidence: PMID 11238540. Use only with clinician guidance in diabetes or kidney disease.
What to test, the optimal window inside the conventional range, and how long a response takes.
Vanadyl sulfate and vanadium supplementation raise serum vanadium and have been studied (with mixed results) for insulin sensitivity.5,13
High-dose vanadium (above 1.8 mg per day) can cause GI distress and is not recommended long-term. HbA1c and fasting glucose are useful functional markers.
Vanadium and chromium both have insulin-sensitizing, glucose-lowering activity, so combining them can produce additive reductions in blood glucose and risk of hypoglycemia, particularly in people on diabetes medication.
Recommendation: Avoid stacking unless supervised by a clinician. People taking antidiabetic drugs should monitor blood glucose closely and watch for signs of hypoglycemia.
Vanadium has insulin-mimetic glucose-lowering activity and berberine is a potent glucose-lowering compound, so combining them can additively reduce blood glucose and increase the risk of hypoglycemia.
Recommendation: Avoid combining without medical supervision. If used together, monitor blood glucose, especially when also taking antidiabetic medications, and watch for hypoglycemia symptoms.
Vanadium acts as an insulin mimetic and alpha-lipoic acid improves insulin sensitivity and glucose uptake, so the pair can additively lower blood glucose and raise hypoglycemia risk.
Recommendation: Use together only with clinician oversight. Monitor blood glucose, particularly if taking insulin or other antidiabetic agents, and be alert for hypoglycemia.
Vitamin C directly alters the chemistry of co-ingested vanadium by reducing vanadate (V) to vanadyl (IV). This is one of the best characterized vanadium redox interactions in the inorganic chemistry and toxicology literature, with supporting human serum and EPR data. The practical upshot is mixed rather than purely harmful: ascorbate is widely described as one of the most effective and least toxic agents for reducing vanadium toxicity, so the combination tends to blunt vanadium's pro-oxidant risk. At the same time, it changes which vanadium species is present, which can shift bioavailability and effect, so the two should be thought of as chemically coupled rather than independent.
Recommendation: This combination is generally protective against vanadium's pro-oxidant toxicity rather than dangerous, and high-dose vitamin C is sometimes used deliberately to mitigate vanadium overexposure. If you take vanadium for glucose support (typically a few mg up to roughly 25 to 100 mg elemental vanadium daily in studies, far above the trace dietary range), be aware that pairing it with substantial vitamin C, roughly 500 mg or more, will reduce and re-speciate the vanadium. If you want to evaluate vanadium's own effect cleanly, separate dosing by 3 to 4 hours; if your goal is to limit vanadium toxicity, co-dosing is reasonable. Keep total vanadium modest and time-limited regardless.
Taken together, vanadium and fenugreek produce an additive blood-glucose-lowering effect documented in experimental diabetic models, where their combination reversed diabetic changes at biochemical and molecular levels (including GLUT4 and insulin endpoints). A useful secondary finding is that adding fenugreek significantly reduced vanadium's toxicity while preserving the glucose-lowering action. The main caution is the stacked hypoglycemic potential, which becomes clinically important when either supplement is layered onto glucose-lowering medication.
Recommendation: If you use both for glucose support, monitor blood glucose, especially when starting, changing doses, or if you also take metformin, a sulfonylurea, or insulin, where the combined effect raises hypoglycemia risk. Watch for shakiness, sweating, or lightheadedness. Keep vanadium modest (most glucose protocols stay well under 25 mg elemental daily and are time-limited) and use typical fenugreek seed doses (roughly 5 to 10 g of seed powder or standardized equivalents with meals). Anyone on diabetes medication should involve their clinician before combining, since medication doses may need adjustment.
Vanadium salts have insulin-mimetic activity and small human studies in type 2 diabetes show improved insulin sensitivity and glucose-lowering effects. Insulin glargine provides basal insulin exposure, so adding vanadium may increase the risk of hypoglycemia, especially with reduced food intake, kidney disease, exercise changes, or other glucose-lowering drugs.
Recommendation: Do not add vanadium to insulin glargine without diabetes-clinician guidance. If it is used, increase glucose monitoring when starting, stopping, or changing vanadium dose, and have a clear plan for treating low blood sugar. Seek urgent care for severe confusion, seizure, fainting, or inability to keep carbohydrates down.
Vanadium has insulin-like signaling effects and has lowered glucose or improved insulin sensitivity in small human diabetes studies. Insulin aspart is a rapid-acting mealtime insulin, so adding vanadium can make post-dose hypoglycemia more likely if carbohydrate intake, exercise, illness, or insulin dosing is not adjusted.
Recommendation: Do not combine vanadium with insulin aspart unless your diabetes clinician is monitoring the change. Check glucose more frequently around meals and activity when vanadium is started, stopped, or dose-adjusted. Treat low glucose promptly and seek urgent help for severe neuroglycopenic symptoms.
Vanadium salts can mimic insulin signaling and have shown glucose-lowering or insulin-sensitizing effects in human type 2 diabetes studies. Insulin lispro is rapid acting, so the combination may increase hypoglycemia risk, especially when meals are delayed, carbohydrates are reduced, or activity increases.
Recommendation: Use vanadium with insulin lispro only with diabetes-clinician oversight. Increase glucose checks around meals, bedtime, and exercise after any vanadium change. Carry fast carbohydrates and seek urgent care for severe or recurrent hypoglycemia.
Vanadium has insulin-like and insulin-sensitizing activity in PubMed-indexed human diabetes studies. Glipizide stimulates insulin release and can cause hypoglycemia, so adding vanadium may increase the chance of low blood sugar, particularly in older adults, kidney disease, missed meals, or dose escalation.
Recommendation: Avoid starting vanadium while taking glipizide unless your diabetes clinician approves and monitoring is planned. Check glucose more often during any vanadium change and report recurrent lows, sweating, tremor, confusion, or nighttime symptoms. Do not self-adjust glipizide dose without clinician guidance.
Vanadium salts have insulin-mimetic effects and have improved insulin sensitivity in small human diabetes studies. Glimepiride is a sulfonylurea with recognized hypoglycemia risk, so adding vanadium may produce excessive glucose lowering, especially with missed meals, renal impairment, older age, or other diabetes drugs.
Recommendation: Do not add vanadium to glimepiride without prescriber review. If a clinician approves the combination, check glucose more frequently during initiation and dose changes, and have a plan for low blood sugar. Seek urgent care for severe confusion, fainting, seizure, or persistent hypoglycemia.
Vanadium has insulin-like effects and has improved glucose metabolism in small human studies. Glyburide is a longer-acting sulfonylurea with a higher hypoglycemia burden than some alternatives, so vanadium may further increase the risk of severe or prolonged low blood sugar.
Recommendation: Avoid vanadium while taking glyburide unless your prescriber specifically recommends it and plans glucose monitoring. Be especially cautious with kidney disease, older age, missed meals, alcohol, or exercise changes. Seek urgent care for severe, recurrent, or hard-to-correct hypoglycemia.
Numbered references. Citations throughout the page link here.
Ghalichi F, Ostadrahimi A, Saghafi-Asl M. Vanadium and biomarkers of inflammation and oxidative stress in diabetes: A systematic review of animal studies. Health promotion perspectives. 2022
Smith DM, Pickering RM, Lewith GT. A systematic review of vanadium oral supplements for glycaemic control in type 2 diabetes mellitus. QJM : monthly journal of the Association of Physicians. 2008
In type 2 diabetic subjects, vanadyl sulfate increased glucose infusion rate approximately 82%, improving hepatic and muscle insulin sensitivity.
Fasting glucose and HbA1c decreased significantly in 150- and 300-mg vanadyl sulfate groups; reduced endogenous glucose production by about 20%.
Vanadyl sulfate improved insulin sensitivity specifically in diabetic subjects but did not alter insulin sensitivity in nondiabetic obese volunteers.
Du XY, Yu YQ, Yang J et al.. Cytotoxicity of Vanadium(IV) and Vanadium(V) on Caco-2 Cells: The Important Influence of Vanadium Speciation. Biological trace element research. 2025
Stachowicz K. Vanadium - good or bad - The role of vanadium in the central nervous system disorders, potential therapeutic targets and its toxicity. Toxicology letters. 2025
Martins FM, Iglesias BA, Chaves OA et al.. Vanadium(V) complexes derived from triphenylphosphonium and hydrazides: cytotoxicity evaluation and interaction with biomolecules. Dalton transactions (Cambridge, England : 2003). 2024
Altaf MA, Shahid R, Naz S et al.. Vanadium toxicity was alleviated by supplementation of silicon in tomato seedlings: Upregulating antioxidative enzymes and glyoxalase system. Plant physiology and biochemistry : PPB. 2024
Martino C, Geraci F, Scudiero R et al.. Vanadium Toxicity Is Altered by Global Warming Conditions in Sea Urchin Embryos: Metal Bioaccumulation, Cell Stress Response and Apoptosis. Journal of xenobiotics. 2024
Organic vanadium compounds are much safer than inorganic salts with no GI discomfort, hepatic or renal toxicity; toxicity increases with valence state.
Ścibior A. Vanadium (V) and magnesium (Mg) - In vivo interactions: A review. Chemico-biological interactions. 2016
Vanadyl sulfate appears safe at therapeutic doses for 6 weeks but does not dramatically improve insulin sensitivity or glycemic control at tolerated doses.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
NutriStack